Literature DB >> 5640870

Inhibition by actinomycin D of DNA and RNA synthesis and of skin carcinogenesis initiated by 7,12-dimethylbenz[a]anthracene or beta-propiolactone.

H Hennings, H C Smith, N H Colburn, R K Boutwell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5640870

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  [Studies on HIV inactivation in allogeneic bone transplants using chemical disinfection and radioactive irradiation].

Authors:  H Knaepler; F Koch; H Bugany
Journal:  Unfallchirurgie       Date:  1992-02

2.  Proliferative parameters of mammalian cell systms and their rôle in tumor growth and carcinogenesis.

Authors:  M F Rajewsky
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1972

3.  Actinomycin-D and dimethylamino-parthenolide synergism in treating human pancreatic cancer cells.

Authors:  Gauri Lamture; Peter A Crooks; Michael J Borrelli
Journal:  Drug Dev Res       Date:  2018-09-17       Impact factor: 4.360

4.  The modification of the renal carcinogenicity of dimethylnitrosamine by actinomycin D and a protein deficient diet.

Authors:  J Hilfrich; H Haas; N Kmoch; R Montesano; U Mohr; P N Magee
Journal:  Br J Cancer       Date:  1975-11       Impact factor: 7.640

5.  A novel triazolonaphthalimide induces apoptosis and inhibits tumor growth by targeting DNA and DNA-associated processes.

Authors:  Liyan Ji; Simin Yang; Shasha Li; Shan Liu; Shunan Tang; Zhongqiu Liu; Xiangbao Meng; Siwang Yu
Journal:  Oncotarget       Date:  2017-06-06

6.  An autoradiographic study of the early effects of 7,12-dimethylbenz(a)anthracene and progesterone on DNA synthesis in rat mammary epithelial cells and subsequent tumour development.

Authors:  A G Jabara; P H Toyne; R J Fisher
Journal:  Br J Cancer       Date:  1972-08       Impact factor: 7.640

7.  Actinomycin D-Activated RNase L Promotes H2A.X/H2B-Mediated DNA Damage and Apoptosis in Lung Cancer Cells.

Authors:  Huijing Yin; Zhengyu Jiang; Shuoer Wang; Ping Zhang
Journal:  Front Oncol       Date:  2019-10-25       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.